Thursday, January 26, 2023 9:22:12 AM
Cypress Development Changes Name to Century Lithium Corp and New Ticker Symbol ‘LCE’ Effective January 30, 2023
January 26, 2023 – Vancouver, Canada – Cypress Development Corp. (TSXV: CYP) (OTCQX: CYDVF) (Frankfurt: C1Z1) (“Cypress” or “the Company”) is pleased to announce that further to its news release dated January 24, 2023, the TSX Venture Exchange (the “TSXV”) has approved the Company’s name change from Cypress Development Corp. to Century Lithium Corp. The Company will also change its trading symbol from ‘CYP’ to ‘LCE’ on the TSXV. The effective date on which the Company will begin trading under the new name and symbol is January 30, 2023. The CUSIP number is 156615106.
The transfer agent of the Company continues to be Computershare Investor Services Inc. There is no change in the capitalization of the Company in connection with the change of name and trading symbol and no action is required by existing shareholders with respect to this matter. Shareholders holding share certificates of the Company can request a replacement certificate, however new certificates are not required and will not be automatically issued.
About Cypress Development Corp
Cypress Development Corp. is a Canadian based advanced stage lithium company, focused on developing its 100%-owned Clayton Valley Lithium Project in Nevada, USA. Cypress is in the pilot stage of testing on material from its lithium-bearing claystone deposit and progressing towards completing a Feasibility Study and permitting, with the goal of becoming a domestic producer of lithium for the growing electric vehicle and battery storage market.
ON BEHALF OF CYPRESS DEVELOPMENT CORP.
WILLIAM WILLOUGHBY, PhD., PE
President & Chief Executive Officer
For further information, please contact:
Spiros Cacos | Vice President, Investor Relations
Direct: +1 604 764 1851 | Toll Free: 1 800 567 8181
Email scacos@cypressdevelopmentcorp.com
www.cypressdevelopmentcorp.com
Recent CYDVF News
- Dual-Listed Lithium Miner Announces Provisional Patent News • AllPennyStocks.com • 09/07/2023 03:00:00 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM